Headerlogotextwithshieldsshadowed

Tumor Course Faculty – 2023

Course Director

Rakesh K. Jain, Ph.D., Andrew Werk Cook Professor of Radiation Oncology (Tumor Biology), Harvard Medical School; Director, E.L. Steele Laboratories of Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA

Faculty

  • George Coukos, M.D., Ph.D., Professor; Director of Hi-TIDe - Human integrated tumor immunology discovery engine; Head of the Department of oncology; Department of oncology UNIL CHUV, Ludwig Institute for Cancer Research, Lausanne, Switzerland

  • Lisa M. Coussens, Ph.D., Hildegard Lamfrom Chair in Basic Science; Professor and Chair, Cell and Developmental Biology; Associate Director for Basic Research, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA

  • Gordon J. Freeman, PhD, Professor, Department of Medical Oncology, Dana-Farber Cancer Institute and Professor of Medicine, Harvard Medical School 

  • Chi Van Dang, M.D., Ph.D., Scientific director, Ludwig Institute for Cancer Research; Professor, Molecular and Cellular Oncogenesis Program, Wistar Institute, Philadelphia, PA, USA

  • Nir Hacohen, Ph.D., Director, Massachusetts General Hospital Center for Cancer Immunotherapy, Member, Broad Institute, Boston, MA, USA

  • Rakesh K. Jain, Ph.D., Andrew Werk Cook Professor of Tumor Biology, Harvard Medical School; Director, E.L. Steele Laboratories of Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA

  • Carl H. June, M.D., Richard W. Vague Professor in Immunotherapy, Department of Pathology and Laboratory Medicine; Director of the Center for Cellular Immunotherapies; Director of the Parker Institute for Cancer Immunotherapy; University of Pennsylvania, Philadelphia, PA, USA

  • George W. Sledge, Jr., M.D., Professor of Medicine and Chief, Division of Oncology, Stanford University Medical Center, Stanford, CA, USA 

  • Mario L. Suva, M.D., Ph.D., Associate Professor of Pathology, Massachusetts General Hospital and Harvard Medical School Associate Member at the Broad Institute of MIT and Harvard, Co-Director, Cancer Program, Harvard Stem Cell Institute, Boston, MA, USA

  • Michael D. Taylor, M.D., Ph.D., F.R.C.S., Principal Investigator, The Arthur and Sonia Labatt Brain Tumour Research Centre; Senior Scientist, Developmental & Stem Cell Biology; Associate Professor, Departments of Surgery and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada

  • David A. Tuveson, M.D., Ph.D., Professor and Director, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA

  • Matthew Vander Heiden, M.D., Ph.D., Associate Professor of Biology, Massachusetts Institute of Technology; Associate Director, Koch Institute for Integrative Cancer Research, Cambridge, MA, USA

  • Jennifer A. Wargo, M.D., Professor, Surgical Oncology & Genomic Medicine; Program Director for PRIME TR, MD Anderson Cancer Center, Houston, TX, USA

  • Robert A. Weinberg, Ph.D., Daniel K. Ludwig Professor for Cancer Research at Massachusetts Institute of Technology, Director of the Ludwig Center of the MIT, and American Cancer Society Research Professor

Tumor Course Faculty (1986-present)